The Cannabis Conversation Podcast

This week, we’re joined by Sébastien Béguerie, entrepreneur and founder of Kanavape, Alpha-Cat and Golden Buds.  Together we examine the methodologies and tests involved in the quality control of cannabis, their challenges, and the barriers to achieving consistent quality. Sébastien also shares his reflections on the Kanavape case - a significant milestone for the European CBD industry. → View ful...

This week, we’re joined by Rebekah, Hannah, Fran and Jolyn -  the senior management team at cannabis consumer goods firm, South West Brands. In this episode we explore the firm’s unique community-centric, value driven approach to brand building within consumer goods, upcoming opportunities for growth for cannabis brands in the health and wellness space, and the challenges of marketing CBD brands....

This week, we’re joined by Darwin Millard (aka. ‘The Spock of Cannabis’) - Cannabis Industry Consultant, thought leader, Executive Committee Member of ASTM International’s Technical Commitee. In this episode we explore why standards are needed to regulate the cannabis industry, including how they are set, defined and contribute to consumer safety. → View full show notes, summary, and access resour...

This week, we’re joined by Karan Wadhera, Founder and Managing Partner at Casa Verde Capital, US based venture capital fund focusing exclusively on the cannabis industry.  In this episode we learn how the VC fund is helping to support and develop ancillary businesses, alongside serving the diverse needs of the cannabis industry. Karan also gives us an overview of the cannabis investment landscape...

How Do You Fit Cannabis Into Western Medicine? This week, we’re joined by Dr. Ruth Fisher, economist, Co-Founder of CannDynamics and author of The Medical Cannabis Primer. In this show, we explore the market drivers behind the western medical system and its commoditisation of pharmaceuticals, alongside some of the difficulties and complexities faced integrating medical cannabis into the rigid inte...

What is Cannabinoid Hyperemesis Syndrome (CHS)? This week, we welcome back Dr. Ethan Russo, physician, researcher, and leading expert in the field of Medicinal Cannabis.  In this episode, Dr Russo shares the latest research and findings of the largest study on CHS to date - in which his team identified 6 potential genetic targets to assist in the diagnosis and treatment of the condition. → View fu...

This week, we’re joined by Dr. Stephen Barnhill (CEO) & Rod Mcllree (Investor and Advisor) from Apollon Formularies, medical cannabis company based in Jamaica. We investigate Dr. Barnhill’s pioneering research into the use of medical cannabis for cancer, Jamaica’s medical trial and licensing rules, and the influence of the Rastafari on the evolving domestic industry. → View full show notes, su...

This week, we welcome back to the show Dr. Markus Roggen, President and CSO of Delic Labs (formerly Complex Biotech Discovery Ventures) - licensed cannabis and psilocybin research laboratory in Vancouver. We explore the function and potential therapeutic uses of psilocybin, the similarities between the cannabis and mushroom industries, and how Delic Labs is driving R+D within the emerging mushroom...

This week, we welcome back Aurélien Bernard and Benjamin-Alexandre Jeanroy, Co-Founders of Augur Associates - French cannabis consultancy based in Paris. In this episode, our guests update us on the current regulations and restrictions of cannabis production and use in France, we also discuss France’s new medical cannabis trial, and how the country’s traditionally conservative opinions towards can...

This week, we’re joined by Matt Clifton, CEO of Product Earth and founder of Marketing Agency, Milk & Amber. In this episode, we explore the biggest marketing and advertising challenges within the cannabis space, the importance of brand building, and how to target cannabis consumers. → View full show notes, summary, and access resources here:  https://www.canverse.global/shownotes/e11 6 About...

This week, we’re joined by Yoko Miyashita, CEO of Leafly - the world’s largest cannabis informational and educational resource. In this episode, we explore how the Covid-19 pandemic forced innovation within the industry, and the findings of Leafly’s ‘Jobs 2021’ report which investigates the rapid acceleration of the cannabis job market in the USA. → View full show notes, summary, and access resour...

This week, we welcome back Deepak Anand (CEO) and Nick Pateras (Managing Director, Europe) of Materia - Cannabis and CBD supply and distribution company serving the growing cannabis and CBD markets in Europe. In this episode, we investigate the different types of medical cannabis, the importance of Good Manufacturing Process (GMP), and the globalisation of the medical cannabis supply chain. → View...

This week’s guest on the Cannabis Conversation is Ken Clement, Executive Chairman of PRM Inc. - a vertically integrated Canadian phytopharmaceutical company. In this show, we explore how manipulating environmental conditions can help to produce standardised plant compounds for medical use, and how this complex process differs from GMO. → View full show notes, summary, and access resources from thi...

This week, we welcome Andrew DeAngelo to the show, Cannabis Industry Consultant, Entrepreneur, and long time activist. Together, we explore California’s cannabis history including why the booming illegal market is so successful despite adult use being decriminalised, and why Humboldt County became one of the most widely celebrated cannabis cultivation regions. → View full show notes, summary, and...

This week we’re pod-swapping with our friends over at The Cannabis Enigma podcast by Cannigma. This episode features Dr. Joseph Morgan, Professor of Cannabis Education at University of The Sciences, Pennsylvania, USA. We explore the role of cannabis in addiction treatment, the problems that federal law poses to medical cannabis research, and cannabis treatment protocol for addiction. Check out The...

This week we’re joined by Rhys Cohen, Australian Cannabis Consultant, and Editor at Large of Cannabiz Australia. In this episode, Rhys gives us a high level overview of cannabis down-under, including its changing public perceptions, patient access to medical products, and progress towards decriminalisation.  → View full show notes, summary, and access resources here:  https://www.canverse.global/s...

How can nanotechnology be used in the cannabis industry? In our latest episode, we’re joined by Tomas Skrinskas, Founder & CEO of Ascension Sciences - Vancouver based contract research and therapeutic development lab specialising in nanoparticle formulation.  This week we explore what nanotechnology is, and how it has been used within the medical cannabis industry to solve drug delivery challe...

In our latest episode, we’re joined by Emma Chasen, Cannabis Educator & Industry Consultant at US based Eminent Consulting.  Listen in as we explore approaches to cannabis education, how the cannabis community has misused cannabis terminology over time, and taxonomy in relation to cannabis.  → View full show notes, summary, and access resources here:  https://www.canverse.global/shownotes/e108...

This week we’re joined by Dr. Jason Mitchell, CEO and Co-Founder of Hemp Fusion - leading US hemp-based CBD company who have recently listed on the Toronto Stock Exchange.  In this episode we get to know the brand, explore the process of being listed, and examine the wide range of benefits and opportunities an IPO can bring. → View full show notes, summary, and access resources here:  https://www....

How do synthetic cannabinoids compare to naturally occurring ones?? This week we’re joined by pharmacologist Dr Saoirse O'Sullivan and pharmacist Dr Andy Yates, experienced cannabis scientists and advisors to Artelo Biosciences. In this episode we take an in-depth look into cannabinoids, exploring the three classes - endocannabinoids, phytocannabinoids and synthetic cannabinoids in detail, al...

In our latest episode, we’re joined by David Kirby, CEO of Avida Global - British medical cannabis company with cultivation and facilities in Colombia. Join us as we explore the benefits and challenges of cultivation in Colombia, the role of epigenetics systems in cultivation, and how to increase the productivity of plants. → View full show notes, summary, and access resources here:  https://www.c...

This week we’re joined by Dr. Stuart Titus, CEO of Medical Marijuana Inc. - developers and retailers of cannabis-derived products, and the first-ever publicly traded cannabis company in the USA. In this episode, we explore some of the current legislation and regulations governing the cannabis industry in the USA, including the SAFE Banking Act and FDA regulation. → View full show notes, summary, a...

This week we’re delighted to be joined by Vera Twomey, mother of Ava (who suffers from Dravet Syndrome, a rare form of epilepsy), medical cannabis advocate, activist, and author of ‘For Ava...’. From the perspective of a mother and caregiver, Vera shares the difficulties and frustrations faced accessing cannabis in Ireland, the importance of access to medical cannabis for children, and the extreme...

This week we’re joined by Cullen Raichart, CEO of GreenBroz - providers of industry-leading automated harvesting solutions for cannabis cultivation.  Together, we explore the differences between ‘wet’ and ‘dry’ harvesting processes, why the processing of cannabis is so intricate, and how machines can allow quality to be maintained at large scale. → View full show notes, summary, and access resourc...

How will the GW pharma deal affect the industry? This week we welcome back Oliver Zugel, CEO and Founder of Foliumed - international producers of pharmaceutical grade cannabis and extracts in Columbia.  Together, we explore the recent acquisition of GW Pharma by Jazz Pharmaceuticals, how CBD, medical cannabis, and pharmaceutical cannabis will differentiate themselves from each other, and how this...